Loyal’s application for drug approval is another step closer to potential approval through the FDA Center for Veterinary ...
Canine longevity company Loyal announces FDA Center for Veterinary Medicine acceptance of the Target Animal Safety (TAS) ...
What if dogs could live longer and healthier lives? Loyal’s Celine Halioua has raised $135 million from top investors to develop canine longevity pills—and expects to get her first conditional ...
Loyal doesn’t have any revenue yet, but Halioua is in conversations with the FDA and has cleared early hurdles. Under the agency’s conditional approval program for innovative veterinary drugs, Halioua ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback